Feb 12 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for fourth-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...
DexCom reported Q4 revenue of $1.26 billion (up 13% YoY) and finished the year above the high end of guidance, delivering a non‑GAAP gross margin of 63.5%, adjusted EBITDA margin of 33.5%, net income ...
Revenue grew 13% year-over-year to $1.260 billion on a reported basis and 12% year-over-year on an organic 1 basis. U.S. revenue grew 11% and international revenue grew 18% on a reported basis and 15% ...
DexCom, which has underperformed its medical equipment and S&P 500 peers in a big way in 2025, could be staring at better prospects next year. Stelo is facing vast and underpenetrated prediabetes and ...
A map view of the new diabetes advocates. [Image courtesy of Dexcom] Dexcom (NSDQ:DXCM) today announced 16 new advocates representing people with diabetes as part of its World Diabetes Day campaign.
Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
Nikola Parichkov (Brandon) was awarded a $10,000 scholarship and had the opportunity to meet sports and cultural icon Billie Jean King. Elon University sophomore and men’s tennis standout Nikola ...
Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...
DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...
DexCom develops and sells continuous glucose monitoring (CGM) systems, which help people with diabetes track their blood sugar levels in real time. Its flagship products include the Dexcom G6 and G7 ...
SAN DIEGO – Dexcom has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared by the Food and Drug Administration in the United States. The ...